NIH-funded research R21 grant

How inherited maternal cells might shape babies’ BCG immune responses

Official title: The effect of inherited maternal cells on BCG-specific T cell responses in HIV exposed and unexposed infants

Funded at Seattle Children's Hospital · NIH-11413444 · Data updated 2026-11-12

In babies born to mothers with HIV exposure, this study looks at whether maternal cells passed before birth affect how well the BCG vaccine sparks immune responses.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionSeattle Children's Hospital
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 5, 2025
Project endAugust 31, 2027
Funding year2026
Award (this year)$244,625
NIH project number5R21HD118582-02
Project IDNIH-11413444 on NIH RePORTER

Who could benefit from this research

Could help

Infants born to HIV-infected mothers, particularly in high TB prevalence settings, who are receiving BCG vaccination.

Less likely to help

Infants not exposed to HIV in utero or those not receiving BCG vaccination may not benefit from this research.

What this research studies

This project explores why some infants exposed to HIV in the womb respond differently to the BCG vaccine. It will examine maternal microchimerism—maternal cells found in newborns—and its connection to CD4+ T cell responses after BCG vaccination. Researchers will use an infant cohort in a high TB and HIV setting to measure immune markers and correlate them with birth MMc levels. The goal is to uncover factors that could inform better vaccination strategies for vulnerable infants.

Why it matters

Potential benefit: If successful, findings could lead to more effective TB vaccination approaches for HIV-exposed infants.

How similar studies have gone: Preliminary data suggest MMc influences BCG-specific T cell responses, but this area remains exploratory and needs confirmation in larger cohorts.

Where this research is happening

  • Seattle Children's Hospital
    Seattle, United States
    Active

Researchers

  • Principal investigator: Harrington, Whitney Elizabeth — Seattle Children's Hospital
  • Study coordinator: Harrington, Whitney Elizabeth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.